Daniel J. O'Connor - Jan 4, 2024 Form 4 Insider Report for SEELOS THERAPEUTICS, INC. (SEEL)

Role
Director
Signature
/s/ Michael Golembiewski, as attorney-in-fact for Daniel J. O'Connor
Stock symbol
SEEL
Transactions as of
Jan 4, 2024
Transactions value $
$0
Form type
4
Date filed
1/8/2024, 09:45 PM
Previous filing
Dec 11, 2023
Next filing
Mar 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SEEL Stock Option (right to buy) Award $0 +1.67K $0.00 1.67K Jan 4, 2024 Common Stock 1.67K $1.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12th of the shares subject to the option shall vest on February 4, 2024, and 1/12th of the shares subject to the option shall vest monthly thereafter.